ULBP3 and plasma cell myeloma: A similar negative correlation with ULBP3 expression on myeloma and NKG2D on BM NK cells was only evident in the BM of ND patients (Figure S4), which is consistent with evidence from Carbone et al. that NKG2D ligands are most elevated on myeloma cells in the BM of early-stage patients [21].